We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| GE Aerospace | NYSE:GE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 1.85 | 1.14% | 164.49 | 165.74 | 162.0101 | 165.30 | 3,967,223 | 01:00:00 |
From May 2019 to May 2024
By Anthony O. Goriainoff
Intelligent Ultrasound Group PLC said Friday that an ultrasound machine using its technology has received premarket clearance from the Food and Drug Administration for sale in the U.S.
The London-listed developer of AI-based ultrasound and simulation software said GE Healthcare's Voluson SWIFT ultrasound machine incorporates GE Healthcare's SonoLyst software with Intelligent Ultrasound's ScanNav Assist AI technology.
The company said SonoLyst is the first artificial-intelligence software to be launched under its long-term license and co-development agreement with GE Healthcare, and that the first royalty per unit revenues are expected at the start of 2021.
"SonoLyst is an exciting new scanning aid in women's healthcare and FDA clearance for the Voluson SWIFT opens up the important U.S. market," the company said.
Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
October 30, 2020 04:38 ET (08:38 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year GE Aerospace Chart |
1 Month GE Aerospace Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
